CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6898 result(s)

Impact of radiation wait times on risk of local recurrence of breast cancer: early stage cancer with no chemotherapy

Last Updated: May 5, 2004
Result type: Reports

Technology Name Radiation therapy; typically whole breast radiation after breast conservation surgery (BCS) with or without additional irradiation (boost radiation) localized at the surgery site. Disease/Condition Early stage breast cancer (stages I and II) with no chemotherapy. Technology Description Radiation therapy (RT) involves the use...

Gefitinib for advanced or metastatic non-small cell lung cancer

Last Updated: April 14, 2004
Result type: Reports

Gefitinib is approved as monotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have failed prior platinum-based treatment and docetaxel chemotherapy. Its efficacy when compared to standard treatment and best supportive care is unproven. Common drug-related adverse effects inclu...

Mixed amphetamine salts (Adderall XR)

Last Updated: April 13, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Mixed amphetamine salts
Indications: Attention deficit hyperactivity disorder

  • Brand Name: Adderall XR
  • Manufacturer: Shire BioChem Inc.
  • Project Number: S0010
  • Project Status: Complete
  • Submission Type: New

Pegfilgrastim (Neulasta)

Last Updated: March 29, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Pegfilgrastim
Indications: Neutropenia

  • Brand Name: Neulasta
  • Manufacturer: Amgen Canada Inc.
  • Project Number: S0009
  • Project Status: Complete
  • Submission Type: New

Gastroduodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions

Last Updated: March 10, 2004
Result type: Reports

Technology Name Non-steroidal anti-inflammatory drugs (NSAIDs) Gastroprotective agents: misoprostol, histamine type-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs) Cyclooxygenase (COX)-2 selective NSAIDs: celecoxib, rofecoxib, meloxicam. Disease/Condition Traditional NSAIDs, which are used to treat painful arthr...

Endoscope-based treatments for gastroesophageal reflux disease

Last Updated: March 10, 2004
Result type: Reports

Endoscope-based products for the treatment of more severe forms of gastroesophageal reflux disease provide an alternative to the use of drugs or surgery. Results from case series have shown that selected patients benefit through relief of symptoms and reduction of medication. Reported adverse effects appear to be minor. Efficacy has...